VividVisions. Legal performance marketing Log in

Roundup claims after
the Supreme Court.

Claims allege that exposure to glyphosate-based Roundup caused non-Hodgkin lymphoma. The legal landscape changed in 2026, so we confirm program fit with your firm before screening claimants against your criteria.

Discuss a campaign
Serving law firms nationwide

Summary of public information for law firms. Not legal advice.

Delivery models

Three ways to receive Roundup cases.

The right model depends on your intake capacity and acquisition economics.

At the inquiry

Qualified leads

Claimants screened against your firm’s Roundup criteria, delivered with their responses to your intake team or CRM.

For teams that handle follow-up and conversion.

Discuss qualified leads

At the conversation

Warm transfers

Screened claimants connected directly with your intake team during agreed hours and within your delivery caps.

For teams ready to take a live call.

How live transfers work

At the retainer

Signed retainers

For select programs, acquisition structured around qualified, completed e-signed retainers.

For firms seeking a retained-client model.

About retainer programs

The litigation · October 2026

What firms
should know now.

Litigation moves quickly. We confirm current status, and whether a program fits your firm’s strategy, before launch.

Sources
  1. 2016

    Federal cases centralized

    Federal Roundup cases were centralized as MDL No. 2741 in the Northern District of California.

  2. Mar 2026

    Class settlement

    A Missouri state court preliminarily approved Monsanto’s proposed class settlement for current and future claims, with payments of up to $7.25 billion over as many as 21 years.

  3. Jun 2026

    Supreme Court ruling

    In Monsanto Co. v. Durnell, the U.S. Supreme Court held 7–2 that federal pesticide law (FIFRA) preempts state-law failure-to-warn claims based on Roundup’s label.

Screening

Questions built
from your criteria.

These are the areas Roundup screening typically covers. The exact questions and thresholds come from your firm.

Talk through your criteria
  1. Exposure

    Residential, agricultural or occupational use, and for how many years.

  2. Diagnosis

    Non-Hodgkin lymphoma, its subtype and the date of diagnosis.

  3. Treatment & records

    The treatment received and the records available to document diagnosis and exposure.

  4. Representation & class status

    Whether the claimant is already represented and whether they are covered by, or opted out of, the class settlement.

Questions

What firms ask
about Roundup.

Answers specific to your program are part of the first conversation.

How does the Durnell decision affect Roundup claims?

The Court held that FIFRA preempts state-law failure-to-warn claims tied to Roundup’s label. How it affects other theories and pending cases is a legal question for your firm; we confirm program fit with you before launch.

What is the status of the class settlement?

A Missouri court granted preliminary approval in March 2026 for a settlement of up to $7.25 billion over up to 21 years. As of our October 2026 review, final approval had not been announced.

Can leads include consent documentation?

Where a program requires it, leads can be delivered with a TrustedForm or Jornaya certificate. Call recordings for transfers depend on program support and applicable consent requirements.

Sources

Public sources for this summary.

Summary of public information as of October 2026, for law firms evaluating case acquisition. It is not legal advice, and litigation status changes.

Start a conversation

Let’s look at
your next campaign.

Send the practice area, criteria and volume you have in mind. We’ll talk through the right delivery model and a sensible starting point.

Book a 30-minute intro call

Your inquiry is emailed to our team. This website does not store form entries. Please share business requirements only.

Campaign inquiry

Ready for your email app.

Review the details below. Nothing has been sent.

Open email app

If your email app doesn’t open, copy the inquiry and email info@vividvisions.marketing.

This website

Website privacy

When you send a campaign inquiry, the details you enter are emailed to the VividVisions team. This website does not store form entries. If sending fails, you can instead pass the inquiry to your own email application and choose whether to send it.

This website uses Vercel Web Analytics to count page views and see which pages are read. It does not use cookies or advertising pixels and does not identify individual visitors. Its fonts are served with the website. Hosting and email providers may process technical or message data under their own policies.

This notice covers this corporate website. Consumer campaign pages and claimant forms require separate disclosures appropriate to their data collection and consent processes.

Questions: info@vividvisions.marketing